contract 75A50125C00018
Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection
- Goal: Develop a concentrated intramuscular (IM) tranexamic acid (TXA) injection that can be delivered via prefilled syringe or dedicated autoinjector, and secure FDA approval for this formulation.
- Why it matters: TXA is used to control bleeding; a concentrated IM version in ready-to-use devices could enable faster, easier administration in emergency settings.
- Funding me…
This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector.
Th…
Funding Source
Agency: Administration For Strategic Preparedness And Response
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers